[go: up one dir, main page]

AU2002222811A1 - Peptides from ag85 of mycobacterium and uses thereof - Google Patents

Peptides from ag85 of mycobacterium and uses thereof

Info

Publication number
AU2002222811A1
AU2002222811A1 AU2002222811A AU2281102A AU2002222811A1 AU 2002222811 A1 AU2002222811 A1 AU 2002222811A1 AU 2002222811 A AU2002222811 A AU 2002222811A AU 2281102 A AU2281102 A AU 2281102A AU 2002222811 A1 AU2002222811 A1 AU 2002222811A1
Authority
AU
Australia
Prior art keywords
mycobacterium
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002222811A
Other languages
English (en)
Inventor
Annemieke Geluk
Thomas Henricus Maria Ottenhof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leids Universitair Medisch Centrum LUMC
Original Assignee
Leids Universitair Medisch Centrum LUMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leids Universitair Medisch Centrum LUMC filed Critical Leids Universitair Medisch Centrum LUMC
Publication of AU2002222811A1 publication Critical patent/AU2002222811A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002222811A 2000-11-30 2001-11-30 Peptides from ag85 of mycobacterium and uses thereof Abandoned AU2002222811A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00204268A EP1211260A1 (fr) 2000-11-30 2000-11-30 Peptides de Ag85 de mycobacterium et leurs utilisation
EP00204268.7 2000-11-30
PCT/NL2001/000869 WO2002044205A2 (fr) 2000-11-30 2001-11-30 Peptides derives de ag85 de mycobacterie et utilisations associees

Publications (1)

Publication Number Publication Date
AU2002222811A1 true AU2002222811A1 (en) 2002-06-11

Family

ID=8172363

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002222811A Abandoned AU2002222811A1 (en) 2000-11-30 2001-11-30 Peptides from ag85 of mycobacterium and uses thereof

Country Status (3)

Country Link
EP (1) EP1211260A1 (fr)
AU (1) AU2002222811A1 (fr)
WO (1) WO2002044205A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101468201B (zh) * 2007-12-27 2012-09-05 上海万兴生物制药有限公司 一种结核分枝杆菌多价重组蛋白疫苗的制备
CN108693345A (zh) * 2018-04-12 2018-10-23 北京睿达时代科技有限公司 针对结核病筛查与诊断的组合血清标记物检测试剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0419355B1 (fr) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Polypeptides et peptides recombinantes, acides nucléiques lesencodantes, et l'utilisation de celles-ci pour le diagnostique de la tuberculose
GB0003082D0 (en) * 2000-02-10 2000-03-29 Glaxo Group Ltd Vaccine
GB0006693D0 (en) * 2000-03-20 2000-05-10 Glaxo Group Ltd Vaccine

Also Published As

Publication number Publication date
WO2002044205A3 (fr) 2002-10-17
EP1211260A1 (fr) 2002-06-05
WO2002044205A2 (fr) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU5560600A (en) Running and testing applications
AU4145200A (en) Cyclic compounds and uses thereof
AU2001292997A1 (en) Apparatuses containing multiple force generating elements and uses thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU3753599A (en) Micro-compartmentalization device and uses thereof
AU2002211717A1 (en) Stresscopins and their uses
AU4843500A (en) Destructible surfactants and uses thereof
AU2001238412A1 (en) Reaction and separation methods
AU2002364162A1 (en) Sulfhydryl rifamycins and uses thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2002211370A1 (en) Inhibition of tgf-beta and uses thereof
AU2001248817A1 (en) Form panel and panel holding member
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002307031A1 (en) Thrombospondin-2 and uses thereof
AU2001262963A1 (en) Laminin 15 and uses thereof
AU2002316577A1 (en) Cell-screening assay and composition
AU2002222811A1 (en) Peptides from ag85 of mycobacterium and uses thereof
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2002213398A1 (en) Expression vectors and uses thereof
AUPQ599500A0 (en) Novel peptides, modulatory agents therefor and methods of using them
AU2001277519A1 (en) Bio-probes and use thereof